ArticlePloS one2025
LC-MS analysis and antioxidant, antibacterial, and antidiabetic activity of Jumli Marshi rice from Nepal: An in vitro and in silico investigation to validate their potential as a functional food.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Integrated computational and in vitro investigation to explore the preliminary anti-proliferative and anti-mitotic potential of γ-oryzanol against breast cancer.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Comparative Chemical Profiling, Antioxidant Activity, and Antidiabetic Potential of Four Whole-Grain Red Rice Cultivars from Three Southern Border Provinces of Thailand: An In Vitro and In Silico Investigation.Foods (Basel, Switzerland) · 2026Article
- Article
- Antioxidant, Antibacterial, and Antidiabetic Activities ofTheScientificWorldJournal · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Jumli Marshi (J. Marshi), a native rice cultivar in Nepal, is gaining popularity owing to its health benefits for obesity, hypertension, and diabetes. However, scientific evidence verifying its therapeutic potential is lacking until November 2024. Therefore, we aimed to characterize the phytoconstituents and evaluate the antioxidant, antibacterial, and antidiabetic properties of J. Marshi, along with its ADME toxicity profile, using both in vitro and in silico approaches. Liquid chromatography-mass spectrometry analysis of a 70% methanol extract from J. Marshi identified ten plant-based compounds, including phenolic acids, flavonoids, and γ-oryzanol. The extract exhibited significant antioxidant properties, neutralizing DPPH free radicals with a fifty-percentage inhibitory concentration (IC50) of 42.65 ± 3.9 µg/mL, compared to ascorbic acid's IC50 of 4.12 ± 0.7 µg/mL. It also showed antibacterial activity against Staphylococcus aureus, with a zone of inhibition (ZOI) ranging from 7 to 11 mm and a minimum inhibitory concentration (MIC) of 1.56 mg/mL, compared to standard antibiotics meropenem (ZOI: 24 ± 1.6 mm; MIC: 1.56 mg/mL). The enzymatic assay demonstrated that the J. Marshi extract inhibits fifty percent of enzyme activity at a concentration (EC50) of > 1000 µg/mL for α-amylase and 250 ± 2.5 µg/mL for α-glucosidase, in contrast to the standard acarbose, exhibiting an EC50 of 35.5 ± 1.5 µg/mL for α-amylase and 189.5 ± 1.9 µg/mL for α-glucosidase. In silico docking studies revealed strong interactions of rice phytoconstituents with target protein catalytic residues, particularly gamma-oryzanol for α-amylase (-10.0 kcal/mol) and chlorogenic acid for α-glucosidase (-7.7 kcal/mol), compared to acarbose (-6.9 to -7.1 kcal/mol). ADME toxicity analysis suggested that tricin and gamma-oryzanol had the best drug-likeness and safety profiles. To our knowledge, this is the first study to reveal the presence of bioactive phenolic acids and flavonoids. Furthermore, it offers scientific evidence supporting significant antioxidant and α-glucosidase-inhibitory properties, confirming the potential applications of J. Marshi rice as a functional food used for the management of diabetes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.